
    
      The LIFE Study is a prospective, consecutively enrolling, non-randomized multi center
      post-market registry to evaluate the ultra low profile (14F) Ovation Abdominal Stent Graft
      Platform when using in the Percutaneous Endovascular Aneurysm Repair (P-EVAR) treatment of
      patients with AAA using a Fast-Track EVAR protocol.

      250 study patients will be enrolled at up to 40 institutions. Follow-up period is one month.
    
  